Recent VRNA News
- Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at ATS 2024 • GlobeNewswire Inc. • 05/02/2024 06:00:00 AM
- Verona Pharma to Report First Quarter 2024 Financial Results and Provide Corporate Update • GlobeNewswire Inc. • 04/25/2024 06:00:00 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/08/2024 09:18:34 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 02:40:38 AM
- Andrew Fisher Joins Verona Pharma as General Counsel • GlobeNewswire Inc. • 03/04/2024 07:00:00 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 02:00:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 11:08:57 AM
- Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 02/29/2024 07:00:00 AM
- Verona Pharma to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update • GlobeNewswire Inc. • 02/15/2024 07:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 11:11:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 11:10:37 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/05/2024 09:19:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 11:07:24 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 11:05:12 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 11:02:48 AM
- Michael Austwick Joins Verona Pharma as Non-Executive Director • GlobeNewswire Inc. • 02/01/2024 07:00:00 AM
- Verona Pharma to Present at 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/03/2024 07:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 11:02:23 AM
- Verona Pharma enters into Debt Facility of up to $400 Million with Oxford Finance and Hercules Capital • GlobeNewswire Inc. • 01/02/2024 07:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2023 09:15:16 PM
- Verona Pharma’s President and CEO David Zaccardelli Wins Executive of the Year SCRIP Award • GlobeNewswire Inc. • 11/17/2023 07:00:00 AM
- Verona Pharma Announces November 2023 Investor Conference Participation • GlobeNewswire Inc. • 11/08/2023 07:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2023 12:11:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2023 12:09:56 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/03/2023 08:25:55 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM